SEC Filings

< Back

SEC Filing Details

Document Details

Form

424B5

Filing Date

Nov 8, 2024

Document Date

Nov 8, 2024

Form Description

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

Filing Group

Registration Statements

Company

Polypid

Issuer

PolyPid Ltd.

Filing Formats

View HTML

Download PDF

Download DOC

Download XLS

Technology

PolyPid’s PLEX targeted drug delivery platform enables localized, controlled, continuous release of medication over prolonged periods of time for better patient outcomes.

D-PLEX₁₀₀

Provides safe and effective local antibiotic protection against SSI (surgical Site Infection) at the needed tissues or organs by administration during surgical procedures.

D-PLEX₁₀₀₀

Comprised of antibiotic eluting ß tri-calcium phosphate (ßTCP) granules, designed for bone related infections applications.